Liver Diseases Treatment Market - Global Outlook and Forecast 2022-2028

March 2022 | 118 pages | ID: L8A96AB81A41EN
Market Monitor Global

Abstracts

Liver disease, greenish-yellow or greenish-brown skin, often due to intrahepatic cholestasis, intrahepatic or extrahepatic biliary obstruction.The sex hormone secreted in liver disease cannot degrade and inactivate in time, which leads to hyperemia and dilatation of superficial arterioles.

This report contains market size and forecasts of Liver Diseases Treatment in Global, including the following market information:

Global Liver Diseases Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Liver Diseases Treatment market was valued at 15610 million in 2021 and is projected to reach US$ 28010 million by 2028, at a CAGR of 8.7% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Chemotherapy Drugs Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Liver Diseases Treatment include Abbott Laboratories, Bayer Schering, Eli Lilly, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Takeda Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Liver Diseases Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Liver Diseases Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Liver Diseases Treatment Market Segment Percentages, by Type, 2021 (%)

• Chemotherapy Drugs
• Targeted Therapy
• Anti-Viral Drugs
• Immunoglobulins
• Corticosteroids
• Vaccines
• Anti-Rejection Drugs/Immunosuppressant

Global Liver Diseases Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Liver Diseases Treatment Market Segment Percentages, by Application, 2021 (%)

• Cancer
• Hepatitis
• Cirrhosis
• Other

Global Liver Diseases Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Liver Diseases Treatment Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Liver Diseases Treatment revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Liver Diseases Treatment revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Abbott Laboratories
• Bayer Schering
• Eli Lilly
• Merck
• Novartis
• Pfizer
• Roche
• Sanofi-Aventis
• Takeda Pharmaceutical
• Zydus Pharmaceuticals
• Glaxosmithkline
• Bristol-Myers Squibb
• General Electric
• Koninklijke Philips
• Siemens
• Canon Medical Systems Corp
• Hitachi
• Elekta
• Neusoft Corporation
• Samsung Healthcare
• BPL Medical Technologies
• Cura Healthcare
• Angion Biomedica
• Achillion Pharmaceuticals
• Gilead Sciences
• LG Life Sciences
• Verva Pharmaceuticals
• Shenzhen Kangtai Biological Products
• Raptor Pharmaceuticals
• ProMetic Life Sciences
• Phenex Pharmaceuticals

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Liver Diseases Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Liver Diseases Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL LIVER DISEASES TREATMENT OVERALL MARKET SIZE

2.1 Global Liver Diseases Treatment Market Size: 2021 VS 2028
2.2 Global Liver Diseases Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Liver Diseases Treatment Players in Global Market
3.2 Top Global Liver Diseases Treatment Companies Ranked by Revenue
3.3 Global Liver Diseases Treatment Revenue by Companies
3.4 Top 3 and Top 5 Liver Diseases Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Liver Diseases Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Liver Diseases Treatment Players in Global Market
  3.6.1 List of Global Tier 1 Liver Diseases Treatment Companies
  3.6.2 List of Global Tier 2 and Tier 3 Liver Diseases Treatment Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Liver Diseases Treatment Market Size Markets, 2021 & 2028
  4.1.2 Chemotherapy Drugs
  4.1.3 Targeted Therapy
  4.1.4 Anti-Viral Drugs
  4.1.5 Immunoglobulins
  4.1.6 Corticosteroids
  4.1.7 Vaccines
  4.1.8 Anti-Rejection Drugs/Immunosuppressant
4.2 By Type - Global Liver Diseases Treatment Revenue & Forecasts
  4.2.1 By Type - Global Liver Diseases Treatment Revenue, 2017-2022
  4.2.2 By Type - Global Liver Diseases Treatment Revenue, 2023-2028
  4.2.3 By Type - Global Liver Diseases Treatment Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Liver Diseases Treatment Market Size, 2021 & 2028
  5.1.2 Cancer
  5.1.3 Hepatitis
  5.1.4 Cirrhosis
  5.1.5 Other
5.2 By Application - Global Liver Diseases Treatment Revenue & Forecasts
  5.2.1 By Application - Global Liver Diseases Treatment Revenue, 2017-2022
  5.2.2 By Application - Global Liver Diseases Treatment Revenue, 2023-2028
  5.2.3 By Application - Global Liver Diseases Treatment Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Liver Diseases Treatment Market Size, 2021 & 2028
6.2 By Region - Global Liver Diseases Treatment Revenue & Forecasts
  6.2.1 By Region - Global Liver Diseases Treatment Revenue, 2017-2022
  6.2.2 By Region - Global Liver Diseases Treatment Revenue, 2023-2028
  6.2.3 By Region - Global Liver Diseases Treatment Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Liver Diseases Treatment Revenue, 2017-2028
  6.3.2 US Liver Diseases Treatment Market Size, 2017-2028
  6.3.3 Canada Liver Diseases Treatment Market Size, 2017-2028
  6.3.4 Mexico Liver Diseases Treatment Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Liver Diseases Treatment Revenue, 2017-2028
  6.4.2 Germany Liver Diseases Treatment Market Size, 2017-2028
  6.4.3 France Liver Diseases Treatment Market Size, 2017-2028
  6.4.4 U.K. Liver Diseases Treatment Market Size, 2017-2028
  6.4.5 Italy Liver Diseases Treatment Market Size, 2017-2028
  6.4.6 Russia Liver Diseases Treatment Market Size, 2017-2028
  6.4.7 Nordic Countries Liver Diseases Treatment Market Size, 2017-2028
  6.4.8 Benelux Liver Diseases Treatment Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Liver Diseases Treatment Revenue, 2017-2028
  6.5.2 China Liver Diseases Treatment Market Size, 2017-2028
  6.5.3 Japan Liver Diseases Treatment Market Size, 2017-2028
  6.5.4 South Korea Liver Diseases Treatment Market Size, 2017-2028
  6.5.5 Southeast Asia Liver Diseases Treatment Market Size, 2017-2028
  6.5.6 India Liver Diseases Treatment Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Liver Diseases Treatment Revenue, 2017-2028
  6.6.2 Brazil Liver Diseases Treatment Market Size, 2017-2028
  6.6.3 Argentina Liver Diseases Treatment Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Liver Diseases Treatment Revenue, 2017-2028
  6.7.2 Turkey Liver Diseases Treatment Market Size, 2017-2028
  6.7.3 Israel Liver Diseases Treatment Market Size, 2017-2028
  6.7.4 Saudi Arabia Liver Diseases Treatment Market Size, 2017-2028
  6.7.5 UAE Liver Diseases Treatment Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Abbott Laboratories
  7.1.1 Abbott Laboratories Corporate Summary
  7.1.2 Abbott Laboratories Business Overview
  7.1.3 Abbott Laboratories Liver Diseases Treatment Major Product Offerings
  7.1.4 Abbott Laboratories Liver Diseases Treatment Revenue in Global Market (2017-2022)
  7.1.5 Abbott Laboratories Key News
7.2 Bayer Schering
  7.2.1 Bayer Schering Corporate Summary
  7.2.2 Bayer Schering Business Overview
  7.2.3 Bayer Schering Liver Diseases Treatment Major Product Offerings
  7.2.4 Bayer Schering Liver Diseases Treatment Revenue in Global Market (2017-2022)
  7.2.5 Bayer Schering Key News
7.3 Eli Lilly
  7.3.1 Eli Lilly Corporate Summary
  7.3.2 Eli Lilly Business Overview
  7.3.3 Eli Lilly Liver Diseases Treatment Major Product Offerings
  7.3.4 Eli Lilly Liver Diseases Treatment Revenue in Global Market (2017-2022)
  7.3.5 Eli Lilly Key News
7.4 Merck
  7.4.1 Merck Corporate Summary
  7.4.2 Merck Business Overview
  7.4.3 Merck Liver Diseases Treatment Major Product Offerings
  7.4.4 Merck Liver Diseases Treatment Revenue in Global Market (2017-2022)
  7.4.5 Merck Key News
7.5 Novartis
  7.5.1 Novartis Corporate Summary
  7.5.2 Novartis Business Overview
  7.5.3 Novartis Liver Diseases Treatment Major Product Offerings
  7.5.4 Novartis Liver Diseases Treatment Revenue in Global Market (2017-2022)
  7.5.5 Novartis Key News
7.6 Pfizer
  7.6.1 Pfizer Corporate Summary
  7.6.2 Pfizer Business Overview
  7.6.3 Pfizer Liver Diseases Treatment Major Product Offerings
  7.6.4 Pfizer Liver Diseases Treatment Revenue in Global Market (2017-2022)
  7.6.5 Pfizer Key News
7.7 Roche
  7.7.1 Roche Corporate Summary
  7.7.2 Roche Business Overview
  7.7.3 Roche Liver Diseases Treatment Major Product Offerings
  7.7.4 Roche Liver Diseases Treatment Revenue in Global Market (2017-2022)
  7.7.5 Roche Key News
7.8 Sanofi-Aventis
  7.8.1 Sanofi-Aventis Corporate Summary
  7.8.2 Sanofi-Aventis Business Overview
  7.8.3 Sanofi-Aventis Liver Diseases Treatment Major Product Offerings
  7.8.4 Sanofi-Aventis Liver Diseases Treatment Revenue in Global Market (2017-2022)
  7.8.5 Sanofi-Aventis Key News
7.9 Takeda Pharmaceutical
  7.9.1 Takeda Pharmaceutical Corporate Summary
  7.9.2 Takeda Pharmaceutical Business Overview
  7.9.3 Takeda Pharmaceutical Liver Diseases Treatment Major Product Offerings
  7.9.4 Takeda Pharmaceutical Liver Diseases Treatment Revenue in Global Market (2017-2022)
  7.9.5 Takeda Pharmaceutical Key News
7.10 Zydus Pharmaceuticals
  7.10.1 Zydus Pharmaceuticals Corporate Summary
  7.10.2 Zydus Pharmaceuticals Business Overview
  7.10.3 Zydus Pharmaceuticals Liver Diseases Treatment Major Product Offerings
  7.10.4 Zydus Pharmaceuticals Liver Diseases Treatment Revenue in Global Market (2017-2022)
  7.10.5 Zydus Pharmaceuticals Key News
7.11 Glaxosmithkline
  7.11.1 Glaxosmithkline Corporate Summary
  7.11.2 Glaxosmithkline Business Overview
  7.11.3 Glaxosmithkline Liver Diseases Treatment Major Product Offerings
  7.11.4 Glaxosmithkline Liver Diseases Treatment Revenue in Global Market (2017-2022)
  7.11.5 Glaxosmithkline Key News
7.12 Bristol-Myers Squibb
  7.12.1 Bristol-Myers Squibb Corporate Summary
  7.12.2 Bristol-Myers Squibb Business Overview
  7.12.3 Bristol-Myers Squibb Liver Diseases Treatment Major Product Offerings
  7.12.4 Bristol-Myers Squibb Liver Diseases Treatment Revenue in Global Market (2017-2022)
  7.12.5 Bristol-Myers Squibb Key News
7.13 General Electric
  7.13.1 General Electric Corporate Summary
  7.13.2 General Electric Business Overview
  7.13.3 General Electric Liver Diseases Treatment Major Product Offerings
  7.13.4 General Electric Liver Diseases Treatment Revenue in Global Market (2017-2022)
  7.13.5 General Electric Key News
7.14 Koninklijke Philips
  7.14.1 Koninklijke Philips Corporate Summary
  7.14.2 Koninklijke Philips Business Overview
  7.14.3 Koninklijke Philips Liver Diseases Treatment Major Product Offerings
  7.14.4 Koninklijke Philips Liver Diseases Treatment Revenue in Global Market (2017-2022)
  7.14.5 Koninklijke Philips Key News
7.15 Siemens
  7.15.1 Siemens Corporate Summary
  7.15.2 Siemens Business Overview
  7.15.3 Siemens Liver Diseases Treatment Major Product Offerings
  7.15.4 Siemens Liver Diseases Treatment Revenue in Global Market (2017-2022)
  7.15.5 Siemens Key News
7.16 Canon Medical Systems Corp
  7.16.1 Canon Medical Systems Corp Corporate Summary
  7.16.2 Canon Medical Systems Corp Business Overview
  7.16.3 Canon Medical Systems Corp Liver Diseases Treatment Major Product Offerings
  7.16.4 Canon Medical Systems Corp Liver Diseases Treatment Revenue in Global Market (2017-2022)
  7.16.5 Canon Medical Systems Corp Key News
7.17 Hitachi
  7.17.1 Hitachi Corporate Summary
  7.17.2 Hitachi Business Overview
  7.17.3 Hitachi Liver Diseases Treatment Major Product Offerings
  7.17.4 Hitachi Liver Diseases Treatment Revenue in Global Market (2017-2022)
  7.17.5 Hitachi Key News
7.18 Elekta
  7.18.1 Elekta Corporate Summary
  7.18.2 Elekta Business Overview
  7.18.3 Elekta Liver Diseases Treatment Major Product Offerings
  7.18.4 Elekta Liver Diseases Treatment Revenue in Global Market (2017-2022)
  7.18.5 Elekta Key News
7.19 Neusoft Corporation
  7.19.1 Neusoft Corporation Corporate Summary
  7.19.2 Neusoft Corporation Business Overview
  7.19.3 Neusoft Corporation Liver Diseases Treatment Major Product Offerings
  7.19.4 Neusoft Corporation Liver Diseases Treatment Revenue in Global Market (2017-2022)
  7.19.5 Neusoft Corporation Key News
7.20 Samsung Healthcare
  7.20.1 Samsung Healthcare Corporate Summary
  7.20.2 Samsung Healthcare Business Overview
  7.20.3 Samsung Healthcare Liver Diseases Treatment Major Product Offerings
  7.20.4 Samsung Healthcare Liver Diseases Treatment Revenue in Global Market (2017-2022)
  7.20.5 Samsung Healthcare Key News
7.21 BPL Medical Technologies
  7.21.1 BPL Medical Technologies Corporate Summary
  7.21.2 BPL Medical Technologies Business Overview
  7.21.3 BPL Medical Technologies Liver Diseases Treatment Major Product Offerings
  7.21.4 BPL Medical Technologies Liver Diseases Treatment Revenue in Global Market (2017-2022)
  7.21.5 BPL Medical Technologies Key News
7.22 Cura Healthcare
  7.22.1 Cura Healthcare Corporate Summary
  7.22.2 Cura Healthcare Business Overview
  7.22.3 Cura Healthcare Liver Diseases Treatment Major Product Offerings
  7.22.4 Cura Healthcare Liver Diseases Treatment Revenue in Global Market (2017-2022)
  7.22.5 Cura Healthcare Key News
7.23 Angion Biomedica
  7.23.1 Angion Biomedica Corporate Summary
  7.23.2 Angion Biomedica Business Overview
  7.23.3 Angion Biomedica Liver Diseases Treatment Major Product Offerings
  7.23.4 Angion Biomedica Liver Diseases Treatment Revenue in Global Market (2017-2022)
  7.23.5 Angion Biomedica Key News
7.24 Achillion Pharmaceuticals
  7.24.1 Achillion Pharmaceuticals Corporate Summary
  7.24.2 Achillion Pharmaceuticals Business Overview
  7.24.3 Achillion Pharmaceuticals Liver Diseases Treatment Major Product Offerings
  7.24.4 Achillion Pharmaceuticals Liver Diseases Treatment Revenue in Global Market (2017-2022)
  7.24.5 Achillion Pharmaceuticals Key News
7.25 Gilead Sciences
  7.25.1 Gilead Sciences Corporate Summary
  7.25.2 Gilead Sciences Business Overview
  7.25.3 Gilead Sciences Liver Diseases Treatment Major Product Offerings
  7.25.4 Gilead Sciences Liver Diseases Treatment Revenue in Global Market (2017-2022)
  7.25.5 Gilead Sciences Key News
7.26 LG Life Sciences
  7.26.1 LG Life Sciences Corporate Summary
  7.26.2 LG Life Sciences Business Overview
  7.26.3 LG Life Sciences Liver Diseases Treatment Major Product Offerings
  7.26.4 LG Life Sciences Liver Diseases Treatment Revenue in Global Market (2017-2022)
  7.26.5 LG Life Sciences Key News
7.27 Verva Pharmaceuticals
  7.27.1 Verva Pharmaceuticals Corporate Summary
  7.27.2 Verva Pharmaceuticals Business Overview
  7.27.3 Verva Pharmaceuticals Liver Diseases Treatment Major Product Offerings
  7.27.4 Verva Pharmaceuticals Liver Diseases Treatment Revenue in Global Market (2017-2022)
  7.27.5 Verva Pharmaceuticals Key News
7.28 Shenzhen Kangtai Biological Products
  7.28.1 Shenzhen Kangtai Biological Products Corporate Summary
  7.28.2 Shenzhen Kangtai Biological Products Business Overview
  7.28.3 Shenzhen Kangtai Biological Products Liver Diseases Treatment Major Product Offerings
  7.28.4 Shenzhen Kangtai Biological Products Liver Diseases Treatment Revenue in Global Market (2017-2022)
  7.28.5 Shenzhen Kangtai Biological Products Key News
7.29 Raptor Pharmaceuticals
  7.29.1 Raptor Pharmaceuticals Corporate Summary
  7.29.2 Raptor Pharmaceuticals Business Overview
  7.29.3 Raptor Pharmaceuticals Liver Diseases Treatment Major Product Offerings
  7.29.4 Raptor Pharmaceuticals Liver Diseases Treatment Revenue in Global Market (2017-2022)
  7.29.5 Raptor Pharmaceuticals Key News
7.30 ProMetic Life Sciences
  7.30.1 ProMetic Life Sciences Corporate Summary
  7.30.2 ProMetic Life Sciences Business Overview
  7.30.3 ProMetic Life Sciences Liver Diseases Treatment Major Product Offerings
  7.30.4 ProMetic Life Sciences Liver Diseases Treatment Revenue in Global Market (2017-2022)
  7.30.5 ProMetic Life Sciences Key News
7.31 Phenex Pharmaceuticals
  7.31.1 Phenex Pharmaceuticals Corporate Summary
  7.31.2 Phenex Pharmaceuticals Business Overview
  7.31.3 Phenex Pharmaceuticals Liver Diseases Treatment Major Product Offerings
  7.31.4 Phenex Pharmaceuticals Liver Diseases Treatment Revenue in Global Market (2017-2022)
  7.31.5 Phenex Pharmaceuticals Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Liver Diseases Treatment Market Opportunities & Trends in Global Market
Table 2. Liver Diseases Treatment Market Drivers in Global Market
Table 3. Liver Diseases Treatment Market Restraints in Global Market
Table 4. Key Players of Liver Diseases Treatment in Global Market
Table 5. Top Liver Diseases Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Liver Diseases Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Liver Diseases Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Liver Diseases Treatment Product Type
Table 9. List of Global Tier 1 Liver Diseases Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Liver Diseases Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Liver Diseases Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Liver Diseases Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Liver Diseases Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Liver Diseases Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Liver Diseases Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Liver Diseases Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Liver Diseases Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Liver Diseases Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Liver Diseases Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Liver Diseases Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Liver Diseases Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Liver Diseases Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Liver Diseases Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Liver Diseases Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Liver Diseases Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Liver Diseases Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Liver Diseases Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Liver Diseases Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Liver Diseases Treatment Revenue, (US$, Mn), 2023-2028
Table 30. Abbott Laboratories Corporate Summary
Table 31. Abbott Laboratories Liver Diseases Treatment Product Offerings
Table 32. Abbott Laboratories Liver Diseases Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Bayer Schering Corporate Summary
Table 34. Bayer Schering Liver Diseases Treatment Product Offerings
Table 35. Bayer Schering Liver Diseases Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Eli Lilly Corporate Summary
Table 37. Eli Lilly Liver Diseases Treatment Product Offerings
Table 38. Eli Lilly Liver Diseases Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Merck Corporate Summary
Table 40. Merck Liver Diseases Treatment Product Offerings
Table 41. Merck Liver Diseases Treatment Revenue (US$, Mn), (2017-2022)
Table 42. Novartis Corporate Summary
Table 43. Novartis Liver Diseases Treatment Product Offerings
Table 44. Novartis Liver Diseases Treatment Revenue (US$, Mn), (2017-2022)
Table 45. Pfizer Corporate Summary
Table 46. Pfizer Liver Diseases Treatment Product Offerings
Table 47. Pfizer Liver Diseases Treatment Revenue (US$, Mn), (2017-2022)
Table 48. Roche Corporate Summary
Table 49. Roche Liver Diseases Treatment Product Offerings
Table 50. Roche Liver Diseases Treatment Revenue (US$, Mn), (2017-2022)
Table 51. Sanofi-Aventis Corporate Summary
Table 52. Sanofi-Aventis Liver Diseases Treatment Product Offerings
Table 53. Sanofi-Aventis Liver Diseases Treatment Revenue (US$, Mn), (2017-2022)
Table 54. Takeda Pharmaceutical Corporate Summary
Table 55. Takeda Pharmaceutical Liver Diseases Treatment Product Offerings
Table 56. Takeda Pharmaceutical Liver Diseases Treatment Revenue (US$, Mn), (2017-2022)
Table 57. Zydus Pharmaceuticals Corporate Summary
Table 58. Zydus Pharmaceuticals Liver Diseases Treatment Product Offerings
Table 59. Zydus Pharmaceuticals Liver Diseases Treatment Revenue (US$, Mn), (2017-2022)
Table 60. Glaxosmithkline Corporate Summary
Table 61. Glaxosmithkline Liver Diseases Treatment Product Offerings
Table 62. Glaxosmithkline Liver Diseases Treatment Revenue (US$, Mn), (2017-2022)
Table 63. Bristol-Myers Squibb Corporate Summary
Table 64. Bristol-Myers Squibb Liver Diseases Treatment Product Offerings
Table 65. Bristol-Myers Squibb Liver Diseases Treatment Revenue (US$, Mn), (2017-2022)
Table 66. General Electric Corporate Summary
Table 67. General Electric Liver Diseases Treatment Product Offerings
Table 68. General Electric Liver Diseases Treatment Revenue (US$, Mn), (2017-2022)
Table 69. Koninklijke Philips Corporate Summary
Table 70. Koninklijke Philips Liver Diseases Treatment Product Offerings
Table 71. Koninklijke Philips Liver Diseases Treatment Revenue (US$, Mn), (2017-2022)
Table 72. Siemens Corporate Summary
Table 73. Siemens Liver Diseases Treatment Product Offerings
Table 74. Siemens Liver Diseases Treatment Revenue (US$, Mn), (2017-2022)
Table 75. Canon Medical Systems Corp Corporate Summary
Table 76. Canon Medical Systems Corp Liver Diseases Treatment Product Offerings
Table 77. Canon Medical Systems Corp Liver Diseases Treatment Revenue (US$, Mn), (2017-2022)
Table 78. Hitachi Corporate Summary
Table 79. Hitachi Liver Diseases Treatment Product Offerings
Table 80. Hitachi Liver Diseases Treatment Revenue (US$, Mn), (2017-2022)
Table 81. Elekta Corporate Summary
Table 82. Elekta Liver Diseases Treatment Product Offerings
Table 83. Elekta Liver Diseases Treatment Revenue (US$, Mn), (2017-2022)
Table 84. Neusoft Corporation Corporate Summary
Table 85. Neusoft Corporation Liver Diseases Treatment Product Offerings
Table 86. Neusoft Corporation Liver Diseases Treatment Revenue (US$, Mn), (2017-2022)
Table 87. Samsung Healthcare Corporate Summary
Table 88. Samsung Healthcare Liver Diseases Treatment Product Offerings
Table 89. Samsung Healthcare Liver Diseases Treatment Revenue (US$, Mn), (2017-2022)
Table 90. BPL Medical Technologies Corporate Summary
Table 91. BPL Medical Technologies Liver Diseases Treatment Product Offerings
Table 92. BPL Medical Technologies Liver Diseases Treatment Revenue (US$, Mn), (2017-2022)
Table 93. Cura Healthcare Corporate Summary
Table 94. Cura Healthcare Liver Diseases Treatment Product Offerings
Table 95. Cura Healthcare Liver Diseases Treatment Revenue (US$, Mn), (2017-2022)
Table 96. Angion Biomedica Corporate Summary
Table 97. Angion Biomedica Liver Diseases Treatment Product Offerings
Table 98. Angion Biomedica Liver Diseases Treatment Revenue (US$, Mn), (2017-2022)
Table 99. Achillion Pharmaceuticals Corporate Summary
Table 100. Achillion Pharmaceuticals Liver Diseases Treatment Product Offerings
Table 101. Achillion Pharmaceuticals Liver Diseases Treatment Revenue (US$, Mn), (2017-2022)
Table 102. Gilead Sciences Corporate Summary
Table 103. Gilead Sciences Liver Diseases Treatment Product Offerings
Table 104. Gilead Sciences Liver Diseases Treatment Revenue (US$, Mn), (2017-2022)
Table 105. LG Life Sciences Corporate Summary
Table 106. LG Life Sciences Liver Diseases Treatment Product Offerings
Table 107. LG Life Sciences Liver Diseases Treatment Revenue (US$, Mn), (2017-2022)
Table 108. Verva Pharmaceuticals Corporate Summary
Table 109. Verva Pharmaceuticals Liver Diseases Treatment Product Offerings
Table 110. Verva Pharmaceuticals Liver Diseases Treatment Revenue (US$, Mn), (2017-2022)
Table 111. Shenzhen Kangtai Biological Products Corporate Summary
Table 112. Shenzhen Kangtai Biological Products Liver Diseases Treatment Product Offerings
Table 113. Shenzhen Kangtai Biological Products Liver Diseases Treatment Revenue (US$, Mn), (2017-2022)
Table 114. Raptor Pharmaceuticals Corporate Summary
Table 115. Raptor Pharmaceuticals Liver Diseases Treatment Product Offerings
Table 116. Raptor Pharmaceuticals Liver Diseases Treatment Revenue (US$, Mn), (2017-2022)
Table 117. ProMetic Life Sciences Corporate Summary
Table 118. ProMetic Life Sciences Liver Diseases Treatment Product Offerings
Table 119. ProMetic Life Sciences Liver Diseases Treatment Revenue (US$, Mn), (2017-2022)
Table 120. Phenex Pharmaceuticals Corporate Summary
Table 121. Phenex Pharmaceuticals Liver Diseases Treatment Product Offerings
Table 122. Phenex Pharmaceuticals Liver Diseases Treatment Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Liver Diseases Treatment Segment by Type in 2021
Figure 2. Liver Diseases Treatment Segment by Application in 2021
Figure 3. Global Liver Diseases Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Liver Diseases Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Liver Diseases Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Liver Diseases Treatment Revenue in 2021
Figure 8. By Type - Global Liver Diseases Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Liver Diseases Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Liver Diseases Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Liver Diseases Treatment Revenue Market Share, 2017-2028
Figure 12. US Liver Diseases Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Liver Diseases Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Liver Diseases Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Liver Diseases Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Liver Diseases Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Liver Diseases Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Liver Diseases Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Liver Diseases Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Liver Diseases Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Liver Diseases Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Liver Diseases Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Liver Diseases Treatment Revenue Market Share, 2017-2028
Figure 24. China Liver Diseases Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Liver Diseases Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Liver Diseases Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Liver Diseases Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Liver Diseases Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Liver Diseases Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Liver Diseases Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Liver Diseases Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Liver Diseases Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Liver Diseases Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Liver Diseases Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Liver Diseases Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Liver Diseases Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. Abbott Laboratories Liver Diseases Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Bayer Schering Liver Diseases Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Eli Lilly Liver Diseases Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Merck Liver Diseases Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Novartis Liver Diseases Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Pfizer Liver Diseases Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Roche Liver Diseases Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Sanofi-Aventis Liver Diseases Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Takeda Pharmaceutical Liver Diseases Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Zydus Pharmaceuticals Liver Diseases Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Glaxosmithkline Liver Diseases Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Bristol-Myers Squibb Liver Diseases Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. General Electric Liver Diseases Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Koninklijke Philips Liver Diseases Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Siemens Liver Diseases Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 52. Canon Medical Systems Corp Liver Diseases Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 53. Hitachi Liver Diseases Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 54. Elekta Liver Diseases Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 55. Neusoft Corporation Liver Diseases Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 56. Samsung Healthcare Liver Diseases Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 57. BPL Medical Technologies Liver Diseases Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 58. Cura Healthcare Liver Diseases Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 59. Angion Biomedica Liver Diseases Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 60. Achillion Pharmaceuticals Liver Diseases Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 61. Gilead Sciences Liver Diseases Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 62. LG Life Sciences Liver Diseases Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 63. Verva Pharmaceuticals Liver Diseases Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 64. Shenzhen Kangtai Biological Products Liver Diseases Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 65. Raptor Pharmaceuticals Liver Diseases Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 66. ProMetic Life Sciences Liver Diseases Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 67. Phenex Pharmaceuticals Liver Diseases Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)